Related Experiment Video
Updated: Feb 10, 2026

An Optimized Quantitative Pull-Down Analysis of RNA-Binding Proteins Using Short Biotinylated RNA
Published on: February 17, 2023
Poly(rC) binding protein 2 (PCBP2) promotes the viability of human gastric cancer cells by regulating CDK2
Changyu Chen1, Jun Lei1, Qiang Zheng1
1Department of General Surgery (Gastrointestinal Surgery) The First Affiliated Hospital of Anhui Medicial University Hefei China.
Abstract:
Survival rates for patients with gastric cancer, especially the advanced form, remain poor and the development of targeted treatments is hampered by a lack of efficient biological targets. Poly(rC) binding protein 2 (PCBP2) is an RNA-binding protein that contributes to mRNA stabilization, translational silencing and enhancement and it has been implicated as a promoter of gastric cancer growth. In the present study, we demonstrated that the expression level of PCBP2 was higher in human gastric cancer tissues compared to adjacent normal gastric tissues. A high level of PCBP2 was correlated with worse postoperative relapse-free survival and overall survival rates of gastric cancer patients. Small hairpin RNA-mediated depletion of PCBP2 dramatically decreased the viability of gastric cancer cells. Cyclin-dependent kinase 2 (CDK2) was positively regulated by PCBP2 via a direct 3' UTR binding pathway as determined using a ribonucleoprotein immunoprecipitation assay and a biotin pulldown assay. CDK2 mediated the promoting role of PCBP2. These results suggest that PCBP2 acts as an oncogene in human gastric cancer cells and that functionally depleting PCBP2 could be considered as a potential target for gastric cancer therapy.
Insights
Poly(rC) binding protein 2 (PCBP2) promotes gastric cancer growth and is linked to poor survival rates. Depleting PCBP2 significantly reduced cancer cell viability, suggesting it as a potential therapeutic target.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Gastric cancer, particularly advanced stages, has poor survival rates.
- Effective targeted treatments are limited by a lack of suitable biological targets.
- Poly(rC) binding protein 2 (PCBP2) is an RNA-binding protein implicated in gastric cancer progression.
Purpose of the Study:
- To investigate the role of PCBP2 in human gastric cancer.
- To determine the relationship between PCBP2 expression and patient survival.
- To identify the molecular mechanisms by which PCBP2 promotes gastric cancer.
Main Methods:
- Quantitative analysis of PCBP2 expression in gastric cancer tissues versus normal tissues.
- Correlation analysis between PCBP2 levels and patient survival outcomes.
- Functional studies using small hairpin RNA (shRNA) to deplete PCBP2 in gastric cancer cells.
- RNA-binding assays (ribonucleoprotein immunoprecipitation and biotin pulldown) to identify PCBP2 targets.
- Investigation of Cyclin-dependent kinase 2 (CDK2) regulation by PCBP2.
Main Results:
- PCBP2 expression was significantly higher in gastric cancer tissues compared to adjacent normal tissues.
- Elevated PCBP2 levels correlated with reduced relapse-free and overall survival in gastric cancer patients.
- PCBP2 depletion markedly decreased gastric cancer cell viability.
- PCBP2 directly binds to the 3' UTR of CDK2 mRNA, positively regulating its expression.
- CDK2 was identified as a mediator of PCBP2's tumor-promoting effects.
Conclusions:
- PCBP2 functions as an oncogene in human gastric cancer.
- PCBP2 promotes gastric cancer cell viability and progression, partly through the regulation of CDK2.
- Targeting PCBP2 through functional depletion represents a potential therapeutic strategy for gastric cancer.
Related Concept Videos
Cooperative Binding of Transcription Regulators
Cooperative Binding of Transcription Regulators
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Regulated Protein Degradation
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
The Eukaryotic Promoter Region

